Factors correlated with improvement of endothelial dysfunction during rituximab therapy in patients with rheumatoid arthritis

Factors correlated with improvement of endothelial dysfunction during rituximab therapy in patients with rheumatoid arthritis

Maurizio Benucci,1 Gianantonio Saviola,2 Mariangela Manfredi,3 Piercarlo Sarzi-Puttini,4 Fabiola Atzeni41Rheumatology Unit, Department of Internal Medicine, Hospital di S Giovanni di Dio, Azienda Sanitaria di Firenze, Florence, Italy; 2Rheumatology and Rehabilitation Unit, Salvatore Maugeri Foundati...

Full description

Bibliographic Details
Main Authors:	Benucci M, Saviola G, Manfredi M, Sarzi-Puttini P, Atzeni F
Format:	Article
Language:	English
Published:	Dove Medical Press 2013-03-01
Series:	Biologics : Targets & Therapy
Online Access:	http://www.dovepress.com/factors-correlated-with-improvement-of-endothelial-dysfunction-during--a12476

Similar Items

Safety of rituximab in rheumatoid arthritis
by: F. Atzeni, et al.
Published: (2011-06-01)

Cost Effectiveness Analysis of Disease-Modifying Antirheumatic Drugs in Rheumatoid Arthritis. A Systematic Review Literature
by: Maurizio Benucci, et al.
Published: (2011-01-01)

Factors correlated with the improvement of endothelial dysfunction during Abatacept therapy in patients with rheumatoid arthritis
by: Benucci M, et al.
Published: (2018-06-01)

Early rheumatoid arthritis
by: P. Sarzi-Puttini, et al.
Published: (2011-09-01)

Granulomatosis polyangiitis associated with meningeal involvement: response to rituximab therapy after failure of cyclophosphamide
by: M. Benucci, et al.
Published: (2013-05-01)

Complementary medicine in rheumatoid arthritis
by: F. Atzeni, et al.
Published: (2011-09-01)

Costs associated with rheumatoid arthritis in Italy: past, present, and future
by: Benucci M, et al.
Published: (2016-02-01)

Do we have markers to define the cardiovascular risk in rheumatoid arthritis patients?
by: P. Sarzi-Puttini, et al.
Published: (2011-06-01)

Correlations between immunogenicity, drug levels, and disease activity in an Italian cohort of rheumatoid arthritis patients treated with tocilizumab
by: Benucci M, et al.
Published: (2016-03-01)

B-cell depletion and primary Sjögren’s syndrome: is there a role for rituximab?
by: P. Sarzi-Puttini, et al.
Published: (2011-06-01)

Rituximab therapy in Greek patients with rheumatoid arthritis
by: Haralampos M Moutsopoulos, et al.
Published: (2008-10-01)

Study on the possible role of the -174G>C IL-6 promoter polymorphism in predicting response to rituximab in rheumatoid arthritis
by: F. Fischetti, et al.
Published: (2011-06-01)

Budget impact analysis of the use of rituximab in the treatment of rheumatoid arthritis in Italy
by: Maurizio Benucci, et al.
Published: (2009-03-01)

Quality of life in patients with rheumatoid arthritis during rituximab therapy
by: Tatiana Alekseyevna Raskina, et al.
Published: (2013-06-01)

Quality of life in patients with rheumatoid arthritis during rituximab therapy
by: Tatiana Alekseyevna Raskina, et al.
Published: (2013-06-01)

RITUXIMAB: NEW POTENTIALITIES OF THERAPY FOR RHEUMATOID ARTHRITIS
by: D E Karateev, et al.
Published: (2008-12-01)

Impact of rituximab therapy on endothelial function and other markers of atherosclerosisin patients with active rheumatoid arthritis
by: Aleksandr Vital'evich Volkov, et al.
Published: (2010-12-01)

Rituximab for the treatment of rheumatoid arthritis
by: A Bagust, et al.
Published: (2009-09-01)

Rituximab Therapy in Renal Amyloidosis Secondary to Rheumatoid Arthritis
by: Levent Kilic, et al.
Published: (2018-11-01)

The Impact of Rituximab Therapy on the Chromosomes of Patients with Rheumatoid Arthritis
by: Šekib Sokolović, et al.
Published: (2010-05-01)

B cell reductive therapy with rituximab in the treatment of rheumatoid arthritis
by: Joseph M Tuscano, et al.
Published: (2009-05-01)

Correlation of the score for subjective pain with physical disability, clinical and radiographic scores in recent onset rheumatoid arthritis
by: Turiel Maurizio, et al.
Published: (2002-07-01)

Cardiac involvement in rheumatoid arthritis
by: V. De Gennaro Colonna, et al.
Published: (2011-06-01)

Evaluation of Th9 lymphocytes in peripheral blood of rheumatoid arthritis patients and correlation with anti-tumor necrosis factor therapy: results from an in vitro pivotal study
by: R. Talotta, et al.
Published: (2016-09-01)

Rituximab for the treatment of rheumatoid arthritis: an update
by: Mok CC
Published: (2013-12-01)

PREDICTION OF TOCILIZUMAB AND RITUXIMAB EFFECTIVENESS IN RHEUMATOID ARTHRITIS
by: Volkava M. V.
Published: (2019-11-01)

Endothelial dysfunction in patients with rheumatoid arthritis and comorbidity
by: A. K. Knyazeva, et al.
Published: (2018-01-01)

Grounds for development of endothelial dysfunction in rheumatoid arthritis
by: A P Rebrov, et al.
Published: (2004-05-01)

Endothelial Dysfunction and Inflammation: Immunity in Rheumatoid Arthritis
by: XueZhi Yang, et al.
Published: (2016-01-01)

INSULIN RESISTANCE AND ENDOTHELIAL DYSFUNCTION IN RHEUMATOID ARTHRITIS
by: Alexandru Caraba, et al.
Published: (2016-09-01)

Biomarkers of good EULAR response to the B cell depletion therapy in all seropositive rheumatoid arthritis patients: clues for the pathogenesis.
by: Gianfranco Ferraccioli, et al.
Published: (2012-01-01)

Efficacy of Rituximab on Rheumatoid Leptomeningitis as the First Symptom of Rheumatoid Arthritis
by: Mickaël Chouk, et al.
Published: (2021-04-01)

Rituximab treatment of rheumatoid arthritis: new evidence
by: E L Nasonov, et al.
Published: (2009-06-01)

Update on the use of rituximab for intractable rheumatoid arthritis
by: R John Looney
Published: (2009-07-01)

Seronegative and seropositive rheumatoid arthritis treated with rituximab
by: Velloso Feijoo Maria, et al.
Published: (2012-11-01)

Pain in rheumatoid arthritis: a critical review
by: P. Sarzi-Puttini, et al.
Published: (2014-06-01)

Important Considerations for Examining Endothelial Dysfunction in Rheumatoid Arthritis
by: Aamer Sandoo
Published: (2017-01-01)

Endothelial Dysfunction in Rheumatoid Arthritis: Mechanistic Insights and Correlation with Circulating Markers of Systemic Inflammation.
by: Perle Totoson, et al.
Published: (2016-01-01)

Evaluation of the clinical efficiency of tocilizumab versus rituximab therapy in patients with rheumatoid arthritis
by: Anastasia Sergeyevna Avdeyeva, et al.
Published: (2012-08-01)

Tuberculosis Arthritis in the Wrist While Using Rituximab for Rheumatoid Arthritis Treatment
by: Ulusoy H, et al.
Published: (2020-09-01)

Cannot write session to /tmp/vufind_sessions/sess_0u74c54orgqsjl536jm038ta3g